Prevalence of rectal Mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney Sexual Health Centre.

Background:Sexually transmissible infections (STIs) have been increasing in men who have sex with men (MSM) in recent years; however, few studies have investigated the prevalence or antimicrobial resistance in rectal Mycoplasma genitalium in this group. This study aimed to determine the prevalence and predictors of rectal M. genitalium in MSM attending an urban sexual health service in Sydney, Australia, namely the Sydney Sexual Health Centre (SSHC), as well as estimate the rate of macrolide resistance. Methods: A prospective cross-sectional analysis was conducted of rectally asymptomatic MSM having a rectal swab collected as part of their routine care. Participants self-collected a rectal swab to be tested for M. genitalium and completed a 14-item questionnaire that provided information on behavioural risk factors. The prevalence of rectal M. genitalium was determined and multivariate analysis was performed to assess the associations for this infection. Positive specimens then underwent testing for macrolide-resistant mutations (MRMs) using the ResistancePlus MG assay (SpeeDx, Eveleigh, NSW, Australia). Results: In all, 742 patients were consecutively enrolled in the study. The median age was 31 years (interquartile range 27-39 years), with 43.0% born in Australia. Overall, 19.0% of men were bisexual, 22.9% were taking pre-exposure prophylaxis (PrEP) and 4.3% were HIV positive. The prevalence of rectal M. genitalium was 7.0% (95% confidence interval (CI) 5.3-9.1) overall and 11.8% in those taking PrEP. On multivariate analysis, PrEP use was significantly associated with having rectal M. genitalium (odds ratio 2.01; 95% CI 1.09-3.73; P = 0.01). MRMs were detected in 75.0% (36/48; 95% CI 60.4-86.4%) of infections. Conclusion: Rates of rectal M. genitalium infection were high among asymptomatic MSM attending SSHC and MRMs were detected in 75% of infections. PrEP use was found to be significantly associated with rectal M. genitalium infection. These data contribute to the evidence base for screening guidelines in MSM.

[1]  S. Garland,et al.  Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men , 2018, Sexually transmitted diseases.

[2]  C. Foschi,et al.  Sexually transmitted rectal infections in a cohort of ‘men having sex with men’ , 2018, Journal of medical microbiology.

[3]  N. Jeoffreys,et al.  Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney , 2018, Sexually Transmitted Infections.

[4]  A. Westfall,et al.  High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  P. Horner,et al.  Mycoplasma genitalium Infection in Men , 2017, The Journal of infectious diseases.

[6]  M. Golden,et al.  Developing a Public Health Response to Mycoplasma genitalium , 2017, The Journal of infectious diseases.

[7]  S. Garland,et al.  O12.4 Prevalence of mycoplasma genitaliumand macrolide resistance in asymptomatic men who have sex with men (MSM) attending a sexual health centre , 2017, Sexually Transmitted Infections.

[8]  P. Coyle,et al.  Gardnerella vaginalis and Mollicute detection in rectal swabs from men who have sex with men , 2017, International journal of STD & AIDS.

[9]  M. Unemo,et al.  Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium , 2017, Nature Reviews Urology.

[10]  M. Cusini,et al.  2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.

[11]  E. Munson,et al.  Expansion of Comprehensive Screening of Male Sexually Transmitted Infection Clinic Attendees with Mycoplasma genitalium and Trichomonas vaginalis Molecular Assessment: a Retrospective Analysis , 2016, Journal of Clinical Microbiology.

[12]  M. Hellmich,et al.  Asymptomatic anal sexually transmitted infections in HIV‐positive men attending anal cancer screening , 2016, The British journal of dermatology.

[13]  S. Garland,et al.  The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  W. Bower,et al.  Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  C. Bradshaw,et al.  Management of Mycoplasma genitalium infections – can we hit a moving target? , 2015, BMC Infectious Diseases.

[16]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[17]  P. Halfon,et al.  High Prevalence of Asymptomatic Sexually Transmitted Infections among Men Who Have Sex with Men , 2014, Journal of clinical medicine.

[18]  P. Read,et al.  Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence. , 2014, Sexual health.

[19]  Xiangsheng Chen,et al.  The prevalence of urethral and rectal Mycoplasma genitalium among men who have sex with men in China, a cross-sectional study , 2014, BMC Public Health.

[20]  N. Reinton,et al.  Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men. , 2013, Sexual health.

[21]  S. Garland,et al.  Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis , 2012, PloS one.

[22]  S. Hillier,et al.  Use of Nucleic Acid Amplification Testing for Diagnosis of Anorectal Sexually Transmitted Infections , 2012, Journal of Clinical Microbiology.

[23]  M. Yasuda,et al.  Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin , 2011, Sexually Transmitted Infections.

[24]  M. Yasuda,et al.  Macrolide Resistance–associated 23S rRNA Mutation in Mycoplasma genitalium, Japan , 2011, Emerging Infectious Diseases.

[25]  T. Anderson,et al.  Induced Macrolide Resistance in Mycoplasma genitalium Isolates from Patients with Recurrent Nongonococcal Urethritis , 2011, Journal of Clinical Microbiology.

[26]  N. Verlander,et al.  The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic , 2009, Sexually Transmitted Infections.

[27]  S. Garland,et al.  Mycoplasma genitalium in men who have sex with men at male-only saunas , 2009, Sexually Transmitted Infections.

[28]  S. Tabrizi,et al.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  R. Kohn,et al.  Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006. , 2006, Sexually transmitted diseases.

[30]  D. Taylor-Robinson,et al.  Detection of Several Mycoplasma Species at Various Anatomical Sites of Homosexual Men , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[31]  P. Furr,et al.  Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. , 1991, FEMS microbiology letters.